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The ‘JCO-NMR spectra of carbonylhemoglobins Saint MandC (B 102Asn + Tyr), Malmii (B 97His+Gln), 
H6tel Dieu (j? 99AspdGly) and A, have been determined. The positions of the 13C0 resonances for hemo- 
globins A,, Malmii and H&e1 Dieu were similar indicating similar ligand environments for all. The “CO 
resonance for the /?-subunit of Saint Mandt was upfield-shifted compared to the others. This is evidence 
that structural changes at the j?lO2 position directly affect iron-ligand bonding as well as quaternary struc- 
ture. 
Hemoglobin Carbon monoxide NMR Point mutation Protein cooperativity 
1. INTRODUCTION 
The 13CO-NMR spectrum of heme-bound CO 
reflects the ligand environment. In HbACO and 
MbCO reconstituted with 2,4-disubstituted 
deuterohemes, 13C0 feels electronic effects at the 
porphyrin periphery in a manner predictable from 
the Hammet constants u, Q [I]. The 13C0 
resonance of Hb Ziirich CO @3 63His + Arg) also 
depends upon the nature of the distal residue [2]. 
The solvent was found to influence the 13C0 
resonance position of a carbonylheme protein 
model, N-methylimidazolecarbonylprotoheme [3]. 
Here we report the 13C-NMR spectra of three 
carbonylhemoglobins with mutations at the 42 
interface and a short interpretation of the results. 
HbMii and HbHD are high-affinity hemoglobins 
Abbreviations: Hb A, normal hemoglobin A,; HbHD, 
hemoglobin HBtel Dieu; HbK, hemoglobin Kansas; 
HbMii, hemoglobin MalmG; HbSM, hemoglobin Saint 
MandC; Mb, myoglobin; 6, chemical shift in ppm from 
internal DSS 
with reduced cooperativity [4,5]. Both mutations 
are adjacent to fi 98Va1, which is positioned close 
to heme pyrrole II (Fischer nomenclature) (fig.1). 
The poor functions of HbHD, Hb Kempsey (& 
99Asp --) Asn) and Hb Yakima CB 99Asp + His) 
are due to loss of the hydrogen bond, in the deoxy 
form, between the p 99Asp and the fl42Tyr-94Asp 
residues across the w,& interface. HbSM is a low- 
affinity mutant with reduced cooperativity, and 
the mutation is located close to the heme pyrrole 
3-methyl group. This mutation is similar to HbK @ 
102Asn + Thr) in which the hydrogen bond p 
102Asn/cr 94Asp, of importance to the ligated 
state in HbA, is lost [6]. Two previous reports have 
concluded that the 13C0 resonances of HbCO do 
not respond to mutations at the (Y& interface 
17981. 
2. MATERIALS AND METHODS 
Hemoglobins were isolated by chromatography 
in potassium phosphate, 1 mM EDTA and stored 
in liquid nitrogen as in [9]. The metHB contents 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/86/$3.50 0 1986 Federation of European Biochemical Societies 337 
Volume 202, number 2 FEBS LETTERS July 1986 
214 210 206 214 210 206 
CHEMICAL SHIFT IdI 
Fig. 1. The 13CO-NMR spectrum of mutant hemoglobins 
Malmo and Saint MandC. From 60000 to 220000 
transients were accumulated for each sample. The ‘pH’ 
of the gently stirred samples was determined 
immediately after each experiment. 
were measured by the cyanide method using 6 = 
- 3.0 mM-‘.cm-’ and were found to be HbA, 
4.5; HbMo, 1.3; HbHD, 9.5; HbSM, 5.1% 
metHb. For experiments in 10 mM phosphate, 
1 mM EDTA, pH 7.0 buffer, equal volumes of ‘H 
buffer were added and the samples concentrated to 
2.5-4 mM heme under nitrogen. For experiments 
in Tris, samples were passed through a column of 
Sephadex G-25 equilibrated with 0.1 M Tris, 
0.1 M NaCl, 1 mM EDTA, pH 7.4, and then 
diluted with [‘H]Tris buffer and concentrated as 
above. 
Concentrations were determined on the ox- 
ygenated Hbs using 6576 = 15.15 mM_’ - cm- ‘. All 
13C-NMR spectra were obtained under identical 
conditions at 5.85 T using 16K real data points, in- 
ternal ‘H lock, and a controlled probe temperature 
of 25°C. The pulse repetition rate was 0.8 s and 
the digital resolution 0.047 ppm. Spectra were 
smoothed for display by 5 Hz line-broadening and 
four examples are shown in fig.2. Because of the 
adverse effects of DSS on proteins the chemical 
shifts, well reproducible, are reported using the 
observed DSS frequency of an HbACO + 1 Vo DSS 
sample as reference. r3C-NMR measurements were 
made on a Bruker WM-250 instrument operating 
at 62.89 MHz. Electronic spectra were recorded on 
a Beckman DU-7 spectrophotometer. pH values in 
2H20 are given as read on a Radiometer instru- 
ment and electrode and are denoted ‘pH’. 
3. RESULTS 
The resonance positions of CO bound to the 
various Hbs are given in table 1. The chemical shift 
Table 1 
13C chemical shifts of t3C0 bound to normal and mutant human 
hemoglobins 
Hemoglobin Subunit Tris-NaCl, ‘pH’ 7.4 Phosphate, ‘pH’ 7.0 
s AL-8 6 A&-@ 
A, a 208.91 208.87 
0.43 0.35 
P 208.48 208.52 
Malmo (Y 208.89 208.81 
p 97His-Gln 0.43 0.35 ~ 
P 208.46 208.46 
Hotel Dieu Ly 208.78 
fl99Asp-Gly 0.35 
P - 208.43 
Saint Mande cr 208.97 208.93 
fl 102Asn-Tyr 0.62 0.59 
a 208.35 208.34 
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differences (AS) between the cy- and &chains for 
HbA (20.4 ppm) are in excellent agreement with 
other studies [2]. For HbMoCO in Tris, the posi- 
tions of the r3C0 resonances are very close to and 
Ad exactly equal to that observed for HbACO. For 
HbMoCO and HbHDCO in phosphate they are 
again precisely as observed for HbACO though 
both a and ,& resonances are shifted about 0.1 ppm 
upfield compared to HbACO. The AS values for 
HbSMCO in both Tris and phosphate buffers 
(~0.6 ppm) are larger than that observed for any 
other HbCO. Most of this is due to the upfield 
shift of the i3C0 resonance of HbSMCO, which 
suffers increasing shielding of at least 0.1 ppm 
more than any other fl resonance. 
These resonance positions are uniformly 
1.5 ppm to low field compared to earlier reports 
[7,8]. This effect is probably not due to inclusion 
of ‘Hz0 in the samples, since the oxygenation 
isotherm has been shown to be unaffected by ‘Hz0 
[IO]. The major cause of this difference is probably 
bulk susceptibility because an internal standard 
(DSS) was used here. 
4. DISCUSSION 
Since the resonance positions of 13C0 bound to 
the subunits of the high-affinity HbMo and HbHD 
and to HbACO are very similar, the electronic and 
steric environments must be similar. The 13C0 
bound to the low-affinity P-subunit of HbSM is 
shifted to higher field than with other Hbs. Two 
earlier studies failed to find any difference in the 
resonance positions between HbACO and the 
related low-affinity HbK, probably because of the 
low field strengths then available [7,8]. Our 
observed shift is consistent with a reduction of 
bond strength between @-subunit iron and ligand 
according to previous work [l). A plausible reason 
for this would be that changes in conformation at 
the @lo2 residue, due to loss of the p 102Asn/a 
94Asp hydrogen bond, are communicated to the p 
iron-ligand bond. This finding is consistent with a 
previously proposed mechanism of Hb 
cooperativity which points to the indirect coupling 
between iron and hydrogen bonding at the CY& in- 
terface [I I]. This proposed mechanism also 
predicted strong hydrogen bonding between the /3 
99Asp/(u 42Tyr-94Asp pairs, which has been 
recently confirmed by resonance Raman spec- 
troscopy [12]. 
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